FULWINZ Trademark

Trademark Overview

On Tuesday, November 11, 2014, a trademark application was filed for FULWINZ with the United States Patent and Trademark Office. The USPTO has given the FULWINZ trademark a serial number of 86450968. The federal status of this trademark filing is REGISTERED as of Tuesday, April 3, 2018. This trademark is owned by Glaxo Group Limited. The FULWINZ trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardi...
fulwinz

General Information

Serial Number86450968
Word MarkFULWINZ
Filing DateTuesday, November 11, 2014
Status700 - REGISTERED
Status DateTuesday, April 3, 2018
Registration Number5435780
Registration DateTuesday, April 3, 2018
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 16, 2018

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, November 19, 2014
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGlaxo Group Limited
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS
GB
Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS
GB
Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS

Trademark Events

Event DateEvent Description
Monday, April 3, 2023COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Wednesday, November 9, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, November 9, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, November 9, 2022TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Wednesday, November 9, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, November 9, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, November 9, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, December 9, 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, December 9, 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, April 3, 2018REGISTERED-PRINCIPAL REGISTER
Tuesday, January 16, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 16, 2018PUBLISHED FOR OPPOSITION
Wednesday, December 27, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, December 4, 2017WITHDRAWN FROM ISSUE(NOA)-ITU REQUEST
Thursday, November 30, 2017CASE RETURNED TO EXAMINATION
Thursday, November 30, 2017NOTICE OF ALLOWANCE CANCELLED
Saturday, November 11, 2017TEAS POST PUBLICATION AMENDMENT RECEIVED
Thursday, June 15, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, June 13, 2017SOU EXTENSION 4 GRANTED
Tuesday, June 13, 2017SOU EXTENSION 4 FILED
Tuesday, June 13, 2017TEAS EXTENSION RECEIVED
Thursday, December 15, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, December 14, 2016SOU EXTENSION 3 GRANTED
Thursday, December 1, 2016SOU EXTENSION 3 FILED
Thursday, December 1, 2016TEAS EXTENSION RECEIVED
Saturday, July 2, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, July 1, 2016SOU EXTENSION 2 GRANTED
Tuesday, May 31, 2016SOU EXTENSION 2 FILED
Friday, July 1, 2016CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, May 31, 2016TEAS EXTENSION RECEIVED
Friday, November 20, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, November 18, 2015SOU EXTENSION 1 GRANTED
Wednesday, November 18, 2015SOU EXTENSION 1 FILED
Wednesday, November 18, 2015TEAS EXTENSION RECEIVED
Tuesday, June 23, 2015TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, June 16, 2015NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, April 21, 2015OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 21, 2015PUBLISHED FOR OPPOSITION
Wednesday, April 1, 2015NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, March 17, 2015ELECTRONIC RECORD REVIEW COMPLETE
Friday, March 13, 2015ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Thursday, March 5, 2015APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, March 3, 2015ASSIGNED TO EXAMINER
Wednesday, November 19, 2014NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, November 14, 2014NEW APPLICATION ENTERED

Related Keywords

fulwinz pharmaceutical treatment substances preparations disorders diseases alopecia cognitive obesity metabolic